Company / Return on Equity (ROE)
Annexon, Inc. Return on Equity (ROE) History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-47.1%
FY2024
5-year range
-61.4% / -18.4%
FY2020-FY2024
Trend
+12.0%
vs FY2023
Sector context
#126 of 190
Health Care
What the data says
Annexon, Inc. reports negative total equity of -47.1% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-47.1% in FY2024 with a 3-year CAGR of +9.1%.
Improved from -61.4% to -47.1% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +9.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#126 of 190 in Health CareTop 66% of 190This company -47.1% Sector average -50.3%
▼
+6.2% above sector average
Key checks
Key Insights
- In FY2024, return on equity (roe) increased 12.0% year-over-year.
- Currently 3.1pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -47.1% | +12.0% |
| FY2023 | -53.6% | +12.7% |
| FY2022 | -61.4% | -9.3% |
| FY2021 | -56.2% | -205.1% |
| FY2020 | -18.4% | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026